InvestorsHub Logo
Followers 3
Posts 161
Boards Moderated 0
Alias Born 06/14/2021

Re: leslunier post# 2998

Wednesday, 06/30/2021 8:29:14 AM

Wednesday, June 30, 2021 8:29:14 AM

Post# of 20325
Agree; I'm glad I'm no longer invested financially with this company.

I really enjoy reading their updates though; I find them entertaining psychologically.

They no longer state what they are doing, they state what they 'believe', and 'expect'.

"We believe..."
"We expect..."

-----------------------------------------


The phrase "We believe" occurs 13 times in the document. Here are some examples. I've emboldened them, and also emboldened other terms within the same example that point to doubt.


- "We believe this government recognition of the need for antivirals will provide a significant tailwind for the development of our Tollovir™ antiviral"

- "We believe neutralizing antibody testing will become more critical to help determine robust COVID-19 immunity.”

- "we believe that we can compete for large volume COVID-19 testing business, and we expect to see a resurgence in this testing"

- "We believe that the significant strides we have made at Provista will position the Company to accelerate growth"

- "we believe it is critical to rapidly expand our clinical development programs"

- "We believe this CRO relationship will allow for the rapid expansion of enrollment for Tollovir’s clinical data acquisition"

- "We believe that Tollovir may ultimately represent a new standard of care in the treatment and management of COVID-19 patients"

- "We believe this authorization underscores the emerging need in the marketplace for immune support supplements"

- "we believe that independent funding to support sales and marketing for a Tollovid-focused entity, potentially through crowdfunding, may be the best use of the existing Tollovid commercial material and the best financing path forward"

- "We believe Videssa could ultimately represent a new standard of care in certain areas for breast cancer screening

- "We believe that payers will require patients to undergo amyloid PET imaging prior to prescribing Aduhelm."

- "we believe LymPro could also help drive mid-term value for Todos as progress is made."

- "We believe TBIA could ultimately represent an entirely new blood testing platform"

---------------------------------------------------------

They stated "We Expect" 4 times in the document. Again also emboldened other words of doubt.

- "We expect to build a significant international distribution footprint"

Note: To "Build" is a word/phrase of doubt because it implies it has not been built.

- "we expect to see a resurgence in this testing"

Note: (Resurgence implies it's ceased surging)

- "in identifying international distribution partners for Tollovid, and we expect to begin to make announcements on this front in the third quarter of 2021."

- "we expect Todos core TBIA artificial intelligence testing platform that currently has a CE Mark for Breast Cancer and Colon Cancer to be able to replace Videssa and LymPro"

------------------------------------------------------------

Bonus: "We are also optimistic about the interest we have seen from several potential international distribution partners for our dietary supplement Tollovid"

"We're optimistic" means "Nothing has been agreed to"

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TOMDF News